科學新聞評論:
After 11 patients died across both dosage groups, the team halted the high-dose arm of the trial on day six, citing more heart rhythm problems in the high-dose group, and "a trend toward higher lethality". https://www.sciencealert.com/cli ... -to-safety-concerns